Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Nichole Joslyn Eastham

Surgery of the Hand Reno, NV Medical Doctor

NPI 1902223167 CMS profile 5704464

555 N Arlington Ave, Reno, NV 89503

Open in the dashboard

General payments

$22,026

113 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nichole Joslyn Eastham of Reno, NV is reported in the CMS Open Payments database as having received $22,026 across 113 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Surgery of the Hand profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,408 29
2024 General $8,274 21
2023 General $8,782 16
2022 General $1,561 27
2021 General $991 10
2020 General $1,009 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nichole Joslyn Eastham
  • Surgery of the Hand median
  • Middle half of Surgery of the Hand
  • National median

In program year 2025, general payments to Nichole Joslyn Eastham were reported at $1,408. Among 286 Surgery of the Hand profiles paid that year, the median was $288 and the middle half received between $115 and $1,242.

Show as a table
Year Nichole Joslyn Eastham Surgery of the Hand median Middle half National median
2019 $0 $369 $108–$1,516 $163
2020 $1,009 $153 $56–$898 $114
2021 $991 $261 $84–$1,296 $132
2022 $1,561 $313 $103–$1,562 $149
2023 $8,782 $241 $95–$876 $160
2024 $8,274 $236 $84–$890 $164
2025 $1,408 $288 $115–$1,242 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. TriMed, Inc. $18,262 33 payments
  2. Motiva USA, LLC $893 8 payments
  3. AbbVie, Inc. $514 15 payments
  4. AxoGen $466 4 payments
  5. Integra LifeSciences Corporation $466 6 payments
  6. Stryker Corporation $269 2 payments
  7. Mentor Worldwide LLC $243 9 payments
  8. Endo Pharmaceuticals Inc. $212 21 payments
  9. Galderma Laboratories, L.P. $142 1 payment
  10. Aptis Medical, LLC $131 1 payment
  11. Other $428 13 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $7,352 94 payments
  2. Travel and Lodging $6,558 10 payments
  3. Honoraria $4,000 3 payments
  4. Consulting Fee $3,500 1 payment
  5. Education $616 5 payments
Products named General payments · program years 2020–2025
  1. Tools - WFS $3,950 7 payments
  2. Tools - AFS $3,941 10 payments
  3. Motiva Implant Matrix $773 7 payments
  4. Avance Nerve Graft $466 4 payments
  5. NATRELLE SALINE-FILLED BREAST IMPLANTS $329 11 payments
  6. INTEGRA WOUND MATRIX (THIN) $239 2 payments
  7. INTEGRA MESHED BILAYER WOUND MATRIX $239 2 payments
  8. XIAFLEX $212 21 payments
  9. INTEGRA FLOWABLE WOUND MATRIX $149 1 payment
  10. PRIMATRIX $149 1 payment
  11. Other $2,352 47 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

34

Median for Hand Surgery: 118

Drug cost

$126

Median for Hand Surgery: $615

Branded share of claims

32.4%

Median for Hand Surgery: 34.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 11 $49
Cephalexin Generic 12 $46
Oxycodone Hcl Generic 11 $30

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,399 Part D prescribers listed as Hand Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 33 billing codes

Paid by Medicare

$19,836

Of which drugs: $4,889

Medicare patients

75

Average age 73

Services billed

278

51 women, 24 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 73%
High blood pressure 67%
Ischemic heart disease 23%
Chronic kidney disease 19%
Osteoporosis 19%
Diabetes 17%
Depression 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 21 39 $166

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

113 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery of the Hand in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record